CIMed Healthcare

Tactoset – Injectable Bone Substitute

Tactoset is a synthetic, biocompatible, hyaluronic acid-enhanced, calcium phosphate bone graft substitute material intended for permanent implantation and filling bone voids (known as bone marrow lesions) or defects of the skeletal system that are not intrinsic to the stability of bony structure.

Tactoset hardens post deployment to reinforce weaknesses created by these bone voids by converting to a poorly crystalline hydroxyapatite at body temperature. It is then resorbed and replaced by the growth of new bone during the healing process.

Components

Tactoset material set

  1. Pre-filled mixing syringe
    containing powder
  2. Glass syringe
    containing setting solution
  3. Four 1 mL
    Luer lock syringes
  4. Female-female
    Luer lock connector

Anika delivery cannulas

  1. Drillable outer cannula
    (with removable drillable stylet)
    GAUGE: 3.05 mm (11 Ga)
    LENGTH: 110 mm
  2. Inner cannula
    for end delivery
    GAUGE: 2.41 mm (13 Ga)
    LENGTH: 134.39 mm
  3. Inner cannula
    for side delivery
    GAUGE: 2.41 mm (13 Ga)
    LENGTH: 134.39 mm
  4. Push rod

Anika delivery cannulas provide easier use with mini c-arm

Therapy Advantages

Tactoset supports cell-mediated regeneration of new bone as material is resorbed

Enhanced flowability and injectability

  • ontains hyaluronic acid (HA), a naturally occurring substance in the human body
  • HA enhances delivery of the calcium phosphate
  • Highly flowable and easily injectable through minimally invasive surgery
  • Provides tactile feedback to confirm filling of the bone defect
  • Interdigitates into trabecular bone architecture to fill closed bone voids

Closed mixing system

  • Minimizes environmental exposure
  • Enhances ease of use: no mixing bowls; no mess

Unique cannula design

  • Allows surgeons to easily switch intraoperatively between side and end Tactoset delivery without having to remove and reinsert the outer cannula

Diagnosis

  • X-rays are commonly used to determine severity of osteoarthritis, however BMLs
    cannot be detected on X-ray.
  • BMLs can be identified on fluid sensitive, fat suppressed magnetic resonance imaging
    (MRI)
  • Recognized as an area of intense signal visible on T2-weighted sequences

Tactoset – Injectable Bone Substitute

For more information on Tactoset - Injectable Bone Substitute, please download the Injectable Bone Substitute brochure.